M.A. Villalobos

442 total citations
16 papers, 371 citations indexed

About

M.A. Villalobos is a scholar working on Surgery, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M.A. Villalobos has authored 16 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Pharmacology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M.A. Villalobos's work include Cholesterol and Lipid Metabolism (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Inflammatory mediators and NSAID effects (4 papers). M.A. Villalobos is often cited by papers focused on Cholesterol and Lipid Metabolism (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Inflammatory mediators and NSAID effects (4 papers). M.A. Villalobos collaborates with scholars based in Spain. M.A. Villalobos's co-authors include J.P. De La Cruz, Felipe Sánchez de la Cuesta, José Antonio Llamas Carmona, A. Guerrero, M.M. Arrebola, José Antonio González Correa, P. Ortiz, Júlio Gálvez and Juan Antonio López-Villodres and has published in prestigious journals such as Brain Research, British Journal of Pharmacology and Life Sciences.

In The Last Decade

M.A. Villalobos

16 papers receiving 353 citations

Peers

M.A. Villalobos
M.A. Villalobos
Citations per year, relative to M.A. Villalobos M.A. Villalobos (= 1×) peers Chan-Juan Huo

Countries citing papers authored by M.A. Villalobos

Since Specialization
Citations

This map shows the geographic impact of M.A. Villalobos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Villalobos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Villalobos more than expected).

Fields of papers citing papers by M.A. Villalobos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Villalobos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Villalobos. The network helps show where M.A. Villalobos may publish in the future.

Co-authorship network of co-authors of M.A. Villalobos

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Villalobos. A scholar is included among the top collaborators of M.A. Villalobos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Villalobos. M.A. Villalobos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cruz, J.P. De La, et al.. (2010). Virgin olive oil administration improves the effect of aspirin on retinal vascular pattern in experimental diabetes mellitus. British Journal Of Nutrition. 104(4). 560–565. 9 indexed citations
2.
Cruz, J.P. De La, M.M. Arrebola, M.A. Villalobos, et al.. (2003). Influence of glucose concentration on the effects of aspirin, ticlopidine and clopidogrel on platelet function and platelet–subendothelium interaction. European Journal of Pharmacology. 484(1). 19–27. 20 indexed citations
3.
Arrebola, M.M., et al.. (2003). In Vitro Effects of Clopidogrel on the Platelet-Subendothelium Interaction, Platelet Thromboxane and Endothelial Prostacyclin Production, and Nitric Oxide Synthesis. Journal of Cardiovascular Pharmacology. 43(1). 74–82. 27 indexed citations
4.
Villalobos, M.A., et al.. (2003). Effects of Camonagrel, a Selective Inhibitor of Platelet Thromboxane Synthase, on the Platelet-Subendothelium Interaction. Pharmacology. 69(1). 44–50. 3 indexed citations
6.
Cruz, J.P. De La, et al.. (2002). Effects of the selective inhibition of platelet thromboxane synthesis on the platelet‐subendothelium interaction. British Journal of Pharmacology. 137(7). 1082–1088. 9 indexed citations
8.
Cruz, J.P. De La, et al.. (2000). Antithrombotic Potential of Olive Oil Administration in Rabbits with Elevated Cholesterol. Thrombosis Research. 100(4). 305–315. 51 indexed citations
9.
Cruz, J.P. De La, et al.. (2000). Lipid peroxidation and glutathione system in hyperlipemic rabbits: influence of olive oil administration. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1485(1). 36–44. 62 indexed citations
10.
Cruz, J.P. De La, et al.. (1999). Antioxidant potential of evening primrose oil administration in hyperlipemic rabbits. Life Sciences. 65(5). 543–555. 19 indexed citations
11.
Cruz, J.P. De La, et al.. (1998). Effect of propofol on oxidative stress in an in vitro model of anoxia-reoxygenation in the rat brain. Brain Research. 800(1). 136–144. 52 indexed citations
12.
Villalobos, M.A., et al.. (1998). Effect of dietary supplementation with evening primrose oil on vascular thrombogenesis in hyperlipemic rabbits.. PubMed. 80(4). 696–701. 13 indexed citations
13.
Cruz, J.P. De La, et al.. (1997). EFFECT OF EVENING PRIMROSE OIL ON PLATELET AGGREGATION IN RABBITS FED AN ATHEROGENIC DIET. Thrombosis Research. 87(1). 141–149. 24 indexed citations
14.
Cruz, J.P. De La, et al.. (1995). In vitro effect of mopidamol on platelet-subendothelium interaction. Thrombosis Research. 77(1). 97–103. 1 indexed citations
15.
Villalobos, M.A., et al.. (1994). Effects of α-tocopherol on lipid peroxidation and mitochondrial reduction of tetraphenyl tetrazolium in the rat brain. Brain Research Bulletin. 33(3). 313–318. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026